Intrinsic Value

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

The certificate of source validation is valid for 3 years from date of issue.

Kimia Biosciences gets recognition for supply of pharmaceutical raw material to Bangladesh

Kimia Biosciences hit an upper circuit limit of 20% at Rs 56 after the company said it has been validated for supplying pharmaceutical raw material (Bilastine) to Bangladesh.

Kimia Biosciences hits the roof after validation in Bangladesh

Buzzing stocks: Banks, NMDC, Lambodhara Textiles, Deep Industries, Puravankara, Varun Beverages, KPI Global, Pioneer Embroideries, Rane Holdings, Kimia Biosciences

Stocks that will see action today

Kimia Biosciences reports standalone net loss of Rs 1.27 crore in the September 2021 quarter

Kimia Biosciences standalone net profit declines 83.84% in the June 2021 quarter

Kimia Biosciences reports standalone net loss of Rs 0.91 crore in the March 2021 quarter

BRIEF-Kimia Biosciences Says Sameer Goel Reappointed Chairman & MD

BRIEF-Kimia Biosciences Says Got India Drug Regulator Nod To Manufacture Bilastine

BRIEF-Kimia Biosciences Gets India Drug Regulator Nod To Manufacture Brivaracetam For Sale Or Distribution

Antony Waste Handling Cell, Welspun Corp, UPL, Infibeam Avenues, Birla Tyres, General Insurance Corporation of India, Time Technoplast, Zeal Aqua, Flexituff Ventures International, Kimia Biosciences, CRISIL Ratings, Arihant Superstructures, IDBI Bank, Godrej Agrovet, HealthCare Global Enterprises, N…

Stocks In The News | Wellesley Corporation, Dredging Corporation, HSIL, IRCTC, Barak Valley Cements, Pricol

The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.

BRIEF-Kimia Biosciences Gets Permission To Manufacture And Market ‘Obeticholic Acid’ - Investing.com India

Kimia Biosciences Ltd is an India-based company engaged in manufacturing of bulk drugs addressing to various high potential therapeutic segments. The Company provides its products under various categories active pharmaceutical ingredients (APIs), intermediates and formulations. The Company's commercial products include acotiamide hydrochloride hydrate, azelnidipine, benfotiamine, benidipine hydrochloride, citicoline sodium, gliclazide, levosulpiride, luliconazole, oxaceprol, prucalopride succinate, teneligliptin hydrobromide hydrate, vildagliptin, fimasartantrihydrate potassium, obeticholic acid and ursodeoxycholic acid.

Kimia Biosciences Ltd

Kimia Biosciences Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Kimia Biosciences gets recognition for supply of pharmaceutical raw material to Bangladesh

Kimia Biosciences hits the roof after validation in Bangladesh

Stocks that will see action today

Kimia Biosciences reports standalone net loss of Rs 1.27 crore in the September 2021 quarter

Kimia Biosciences standalone net profit declines 83.84% in the June 2021 quarter

Kimia Biosciences reports standalone net loss of Rs 0.91 crore in the March 2021 quarter

BRIEF-Kimia Biosciences Says Sameer Goel Reappointed Chairman & MD

Kimia Biosciences Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Kimia Biosciences gets recognition for supply of pharmaceutical raw material to Bangladesh

Kimia Biosciences hits the roof after validation in Bangladesh

Stocks that will see action today

Kimia Biosciences reports standalone net loss of Rs 1.27 crore in the September 2021 quarter

Kimia Biosciences standalone net profit declines 83.84% in the June 2021 quarter

Kimia Biosciences reports standalone net loss of Rs 0.91 crore in the March 2021 quarter

BRIEF-Kimia Biosciences Says Sameer Goel Reappointed Chairman & MD

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock